Antibiotic treatment of intraabdominal infections;Antibiotikatherapie bei intraabdominalen infektionen

Intensiv- und Notfallbehandlung

Volumn 27, Issue 1, 2002, Pages 16-22

  Hau, T ^a  

^a Klinik fur Allgemein Thorax   (Germany)

Author keywords

Antibiotic therapy; Bacteriology; Intraperitoneal infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMPHOTERICIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; FLUCONAZOLE; IMIPENEM; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC THERAPY; HUMAN; PERITONITIS; REVIEW;

EID: 0036252568     PISSN: 09475362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. A review: Lessons from an animal model of intra abdominal sepsis
2. Piperacillin-Tazobactam versus Imipenem-Cilastatin for treatment of intraabdominal infections
3. Guidelines for clinical care: Antiinfective agents for intraabdominal infection
4. Acute necrotizing pancreatitis: Treatment strategy according to the status of infection
5. Definition of the role of enterococcus in intra-abdominal infection: Analysis of a prospective randomized trial
6. Endotoxin promotes the translocation of bacteria from the gut
7. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and bacteroides fragilis with fibrin clots
8. Secondary pancreatic infections: Are they distinct clinical entities?
9. Role of antibiotics in acute pancreatitis: A metaanalysis
10. Secondary bacterial peritonitis: The biologic basis of treatment
11. Surgical sepsis: Constancy of antibiotic susceptibility of causative organisms
12. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy
13. Pathogenicity of enterococci in a rat model of fecal peritonitis
14. Tertiary peritonitis: Clinical features of a complex nosocomial infection
15. Prognostic modelling in peritonitis
16. Coverage of enterococci in community acquired secondary peritonitis: Results of a randomized trial
17. Intraoperative peritoneal lavage
18. Results of a randomized trial comparing sequential intravenous/oral treatment with Ciprofloxacin plus Metronidazole to Imipenem/Cilastatin for intraabdominal infections
19. Incidence and significance of intraperitoneal anaerobic bacteria
20. Abdominal trauma, anaerobes, and antibiotics
21. Parenterale antibiotika bei erwachsenen
22. Intestinal bacteria translocate into experimental intraabdominal abscesses
23. Management of secondary peritonitis
24. The role of pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis